Bayer AG - Stockholders' Newsletter Third Quarter 2007 - Statements of Recognized Income and Expense

4 of 6

Financial Statements

Bayer Group Consolidated Statements of Recognized Income and Expense

	3rd Quarter 2006	3rd Quarter 2007	First Nine Months 2006	First Nine Months 2007
€ million
Changes in fair values of derivatives designated as hedges and available-for-sale financial assets, recognized in stockholders’ equity	(39)	76	(51)	74
Changes in actuarial gains/losses on defined benefit obligations for pensions and other post-employment benefits, recognized in stockholders’ equity	(852)	167	335	1,272
Exchange differences on translation of operations outside the euro zone, recognized in stockholders’ equity	47	(477)	(428)	(470)
Deferred taxes on valuation adjustments offset directly against stockholders’ equity	353	(184)	(108)	(615)
Changes due to changes in scope of consolidation	-	-	-	36
Valuation adjustments recognized directly in stockholders’ equity	(491)	(418)	(252)	297
Minority interests in partnerships, recognized in stockholders’ equity	-	(5)	-	(24)
Income after taxes	320	1,178	1,372	4,645
Total income and expense recognized in the financial statements	(171)	755	1,120	4,918
of which attributable to minority interest	(3)	1	(6)	(1)
of which attributable to Bayer AG stockholders	(168)	754	1,126	4,919